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Effects and Components of 
Placebos with a Psychological 
Treatment Rationale – Three 
Randomized-Controlled Studies
Jens Gaab1, Joe Kossowsky1,2, Ulrike Ehlert3 & Cosima Locher1
In recent years, placebos have evolved from a mean to control for ‘therapeutic chaff’ to something 
that has clinically relevant effects with biological underpinning and that is considered to have clinical 
as well as scientific potential. However, the wealth of scientific placebo research is conceptualized 
in a biomedical context, i.e. based on placebos provided with a biomedical treatment rationale, 
whereas little is known about effects and mechanisms of placebos provided with a psychological 
treatment rationale. This has important repercussions not only on placebo research, but also on 
attempts to establish specificity of psychological interventions, such as psychotherapy. Therefore, 
we set out to assess the effects and possible components of placebos provided with a psychological 
treatment rationale in three experiments on healthy subjects. We show that placebos provided with a 
psychological treatment rationale are effective in short- as well as mid-term, but only when provided by 
a trustworthy, friendly and empathetic experimenter. These findings indicate that placebos are effective 
outside the medical context and thus need be controlled for in non-medical trials. Furthermore, it 
highlights and confirms the importance of a plausible psychological treatment rationale in the context 
of a therapeutic alliance for psychological interventions, such as psychotherapy.
Placebos are valuable for clinical science in at least two ways. First, they help to scrutinize specific effects of 
medical interventions in the so-called gold standard of clinical investigation, i.e. randomized placebo-controlled 
trials1. Next, genuine placebo research helps to elucidate placebos’ true effects and mechanisms of treatment com-
ponents caused by anything other than the active verum, which in turn can be clinically harnessed2,3.
In general, placebos are thought to mimic their active counterparts up to the point of indistinguishability, 
thus controlling for anything but the purposely active ingredient. But whereas placebos in the context of medical 
interventions, i.e. the classical ‘sugar pill’ provided with a biomedical treatment rationale “This is a potent pain 
killer, which will reduce inflammation and thus pain”, are extensively tried and tested, placebos provided with a 
psychological treatment rationale, such as “Working through your conflict will reduce your pain”, have received 
considerably less empirical scrutiny. Of course, so-called ‘placebo control conditions’, ‘attention controls’, ‘active 
controls’ or ‘non-directive controls’ are commonly used in trials testing psychological interventions, but have 
been found to be ripe with conceptual as well as pragmatic problems4. Accordingly, this led to varying esti-
mates of specificity relative to the operationalization of the placebo condition and researchers’ allegiance1,5–8. 
Placebo conditions in trials of psychological interventions are not only structurally different and thus clearly 
distinguishable from its assumed verum comparator, but they often also lack components which are clearly not 
specific to psychological interventions, such as talking about emotional problems. For example, in a clinical trial 
of cognitive behavior therapy for depressed elderly patients, therapists in the control condition were instructed 
to discuss ‘neutral topics such as hobbies, sports, and current affairs. (…)’ with ‘little focus on emotional issues.’ 
(cited from9). Accordingly, the validity of placebos in clinical research on psychological interventions has been 
questioned10 as the main prerequisite for placebo-controlled trials – single or preferable double blinding – is not 
applicable, ridiculing the goal of the attempt.
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Importantly, it needs to be noted that placebo control conditions in psychotherapy trials – even when dis-
regarding their lack of validity – would throw only little light on the effects of placebos provided with a psy-
chological treatment rationale, because their consequences are best considered as placebo responses. The latter 
are understood to encompass both placebo effects as well as spontaneous remission, regression to the mean, 
detection ambiguity and unidentified co-interventions, whereas placebo effects are understood as differences 
between placebo administration and no treatment11. Also, the quest for valid placebos provided with a psycho-
logical treatment rationale should not be mistaken with placebos provided with a biomedical treatment rationale 
having effects on psychological parameters, such as the anxiety, disgust, empathy, stress, emotional well-being or 
social trust12–19,20 nor with mindset-changing information having effects on subjective outcome, such as perceived 
exercise21.
However, the comparative lack of research on placebos provided with a psychological treatment rationale is 
neither warranted nor inconsequential as psychological interventions are often first-line treatments or integral 
components in the clinical management of mental disorders and considering that their specificity is subject to 
debate22. Thus, it seems non-acceptable from a scientific, clinical, methodological and ethical point of view to 
abandon attempts to examine effects of placebos provided with a psychological treatment rationale and conse-
quently to estimate specific and unspecific effects in the realm of psychological interventions23. Based on these 
considerations, we set out to assess the effects of otherwise inert interventions provided with a psychological 
treatment rationale in three independent studies. Furthermore, we tested the modulation of possible placebo 
effects by the interpersonal behavior of the experimenter. These results will inform the debate on placebos pro-
vided with a psychological treatment rationale and scientific attempts to establish specificity of psychological 
interventions.
Methods
Participants and design. Three independent and consecutive randomized controlled experiments in 
healthy participants were conducted, i.e. the green dot-, green flux- and green morph-experiment. Interested 
subjects were enrolled amongst students of the University of Zürich (green dot-experiment) and the University 
of Basel (green flux- and green morph-experiment). Inclusion criteria were being between 18 and 50 years of 
age, no presence of a mental disorder and no psychological or psychiatric treatment (current or during the last 6 
months) as well as no current usage of medication by self-report. Before randomization, interested subjects were 
informed that the study examines the influence of visual information, but they were not informed that the study 
encompasses an intervention and its evaluation. Up to randomization, experimenters were naïve about group 
assignment of the respective participant. To control for any influence of verbal or interpersonal behavior of the 
experimenters before randomization, verbal and interpersonal behavior of experimenters was manualized (see 
Appendix) as well as minimal and neutral.
In the green dot-experiment, participants signed the informed consent and completed a baseline assessment 
of the primary outcome and then were randomly assigned to three experimental conditions (for description 
see below). After randomization, participants received the intervention placebo according to group assignment. 
Participants then completed a questionnaire to assess the secondary outcome and underwent the placebo (see 
below). After the placebo, participants completed the post assessment of the primary outcome and then were 
debriefed about the aims of the study.
The green flux- and the green morph-experiment consisted of two lab sessions and three assessments of the 
primary outcome (baseline, post and follow-up). The primary outcome was assessed before the randomiza-
tion (baseline assessment), before the second session (post assessment) and seven days after the second session 
(follow-up assessment). At baseline, participants signed the informed consent, completed a baseline assessment 
of the primary outcome and then were randomly assigned to three experimental conditions (for description see 
below). Participants then completed a questionnaire to assess the secondary outcome (see below) and underwent 
the placebo intervention (see below). After the placebo, participants were encouraged to use the placebo as often 
as possible on an individualized website (see Appendix). Adherence to comply with this instruction as well as 
individual access to the website was not assessed. After an interval of a median of 3 days (range 2-3 days), partic-
ipants completed the second assessment of the primary outcome and then underwent the placebo intervention 
a second time in the lab. After the second session, the placebo intervention was still available on websites (see 
Appendix), but participants were not further encouraged to use the placebo.
For all experiments, individual assignment was concealed in sequentially numbered envelopes and opened 
in the presence of participants. Participants were stratified according to sex to control for unequal numbers of 
male and female participants. Participants who enrolled in the study receive credit points accountable for their 
Bachelor studies or participated in a draw for cinema tickets. To control for possible experimenter effects, allo-
cation of experimenter to condition was stratified. For all experiments, ethical approval was obtained from the 
Ethics Committee of the Canton Stadt Basel and Baselland (EKBB; green dot and green flux studies) as well as 
its successor Ethics Committee of Northwest and Central Switzerland (EKNZ, green morph study) and all three 
experiments were performed in accordance with the relevant guidelines and regulations. Informed consent was 
obtained from all participants.
Experimental conditions. In all experiments and all conditions, all subjects received placebos, which 
consisted of animated videos. The placebo in the green-dot-experiment consisted of a 5-minute video (http://
youtu.be/e_SmspvY6qE) of a moving green circle (4.2 cm diameter, green color: RGB 102, 177, 50), presented 
full screen on 15-inch Apple MacBook monitor with full screen brightness. The green circle moved in an unpre-
dictable manner, thus making various turns and changes in speed. In the green flux-experiment, the placebo con-
sisted of a 7-minute video (https://www.youtube.com/watch?v=bPt-m15xAEY endlessly looped for 7 minutes) 
of a moving combination of the colors green, white and yellow, which was shown on the full screen of a 23-inch 
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Apple iMac monitor with full screen brightness. The placebo in the green morph-experiment was 6.49-minute 
video of a slowly pulsing green and yellow circles in a changing green background (https://www.youtube.com/
watch?v=8qyt5k83XHs), which was shown on the full screen of a 23-inch Apple iMac monitor with full screen 
brightness. None of the placebo videos contained any sound. The placebos were provided either without or with a 
psychological rational and without or with a trustworthy, friendly and empathetic relationship. Thus, experimen-
tal conditions were fashioned in order to manipulate these known components of placebo24. In all experiments, 
subjects were left alone in the laboratory room to watch the respective videos. Adherence to watching the videos 
was not monitored.
In all three experiments, participants in the ‘control condition’ were told that they are in the control condition 
and that they had to watch an animated video in order to match the timing of the other groups, which would 
receive a real intervention. However, the intervention, i.e. placebo, within each experiment was the same in all 
conditions, but in the ‘control condition’, the placebo was not provided with a psychological treatment rational, 
i.e. was not introduced as an intervention.
In the green dot- and the green flux-experiment, the two ‘placebo conditions’ differed with regard to behav-
ior of the experimenter only. Thus, participants in both placebo conditions were provided with a psychological 
treatment rationale on the effects and the scientific evidence for this intervention, including that the beneficial 
effects of the intervention were not due to biological effects of colors on the brain, but due to psychological 
processes only, such as the “activation of early conditioned emotional schemata through the color green” (see 
Appendix). The psychological treatment rationale for the placebo conditions was fashioned to provide a psycho-
logical explanation and thus not to evoke any biological or neuroscientific assumptions. Also, while the employed 
psychological treatment rationale was intended to maximize response expectancy, it was not informed by any 
real scientific finding or model and all provided “scientific evidence” was made up. However, in contrast to the 
‘placebo only’ condition, in which experimenters were instructed to behave neutral and ‘technical’, experimenters 
in the ‘placebo plus’ condition were instructed to be trustworthy, friendly and empathetic throughout the course 
of the experiment. This trustworthy, friendly and empathetic interaction of experimenter with participants was 
restricted to experiments as there was no interaction between experimenters and participant outside the labora-
tory sessions. All verbal and interpersonal behavior of experimenters in all studies and conditions was manual-
ized (see Appendix).
In contrast to the green dot- and the green flux-experiment, a ‘control plus’ condition was added in the green 
morph-experiment, in which the placebo was not provided with a psychological treatment rationale, but exper-
imenters were instructed to be trustworthy, friendly and empathetic. The intention to include this ‘control plus’ 
condition was to test whether possible effects in the ‘placebo plus’ condition were merely caused by the trustwor-
thy, friendly and empathetic behavior of the experimenter.
Outcome measures. The primary outcome in the green dot-experiment was baseline to post assessment 
changes in momentary mood, assessed with the Mehrdimensionale Befindlichkeitsfragebogens (MDBF25), which 
is explicitly designed to assess momentary changes with three subscales, i.e. ‘good/bad’, ‘alert/fired’, ‘calm/agitated’ 
mood. To control for possible sequence effects, parallel versions of the MDBF were randomly allocated in differ-
ent sequence (A-B vs. B-A). The parallel version of the MDBF contains 12 adjectives of momentary mood (e.g. 
“good mood”, “relaxed”) with a 1 to 5 scoring.
In the green flux- and the green morph-experiment, primary outcomes were changes in perceived stress, 
assessed with the German version of the Perceived Stress Scale26. The PSS assesses the degree of perceived stress-
ful situations experienced during the preceding days and 14 items are designed to assess how predictable, uncon-
trollable, and overloaded participants evaluate their lives as being. To be able to assess medium-term effects, we 
changed the wording of the items to assess how participants perceived their stress in the two preceding days.
Secondary outcome in all experiments was perceived interpersonal behavior of the experimenter and response 
expectancy to the intervention, assessed with two questions each (see appendix). Since the interaction between 
experimenter and participants in the control groups in the green dot- and green flux-experiments was minimal 
and the placebos were not introduced as an intervention, secondary outcome was not assessed in the control con-
ditions in these experiments. However, in the green morph-experiment, secondary outcome was also assessed in 
the ‘control plus’ condition in order to assess the impact of the experimental manipulation of the experimenters’ 
interpersonal behavior. Secondary outcome was completed after the manualized instructions and before the pla-
cebo administration in the green dot-experiment and after the placebo administration at the second lab session 
in the green flux- and green morph-experiment.
Statistics. Group differences in demographic and baseline data were calculated with chi-square or univar-
iate analyses. To examine whether the placebo was inert when administered without a therapeutic rationale or 
a trustworthy, friendly and empathetic experimenter, time effects in the control group in all experiments were 
calculated with univariate analyses for repeated measures. Group differences in change scores from baseline were 
analyzed with multivariate analyses. In case of significance, subsequent univariate analyses for short-term (base-
line to post assessment) as well as mid-term (baseline to follow-up assessment) changes were conducted. Least 
significant difference post hoc tests were used to determine differences between conditions. Secondary outcome 
was analyzed with univariate analyses. Effect sizes for individual group change scores in the primary outcome 
were calculated as standardized within group changes and expressed in Cohen’s d ((mean baseline – mean post/
follow-up)/pooled standard deviation). Analyses were performed according to the principle of intention to treat, 
with last observation after the intervention carried forward when follow-up data were missing.
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Results
Overall, N = 421 healthy subjects participated in the three experiments (green dot-experiment N = 85, green 
flux-experiment N = 78, green morph-experiment N = 258). There was no dropout in the green dot-experiment, 
but in the green flux-experiment three participants dropped out due to minor illnesses between baseline and 
post assessment and in the green morph-experiment 19 participants did not complete either the post- (N = 2) 
or the follow up- assessment (N = 17). Randomization resulted in equally distributed groups (‘control’/‘pla-
cebo only’/‘placebo plus’ groups: green dot-experiment N = 28/29/28, green flux-experiment N = 25/25/29; 
‘control’/‘control plus’/‘placebo only’/‘placebo plus’ groups: green morph-experiment N = 63/65/65/65), which 
did not differ significantly (all p > 0.05) in mean age in years (green dot-experiment: 24.6, range 18–44, green 
flux-experiment 24.6, range 18–45, green morph-experiment 24.01, range 18–49) and sex distribution (female/
male: green dot-experiment 82%/18%, green flux-experiment: 79%/21%/, green morph-experiment: 75%/25%). 
Experimenters were 15 female and one male psychology master students (green dot-experiment 5/0, green 
flux-experiment: 3/0, green morph-experiment 7/1; see Acknowledgement) and all experimenters had an equal 
share of participants in all experimental condition (all experiments p > 0.9).
Effects of condition on primary outcome. In the green dot-experiment, moods levels did not change 
significantly over time in the ‘control condition’, indicating that the placebo had no significant effect on mood 
per se (F(1/27) = 0.07, p = 0.79). The experimental manipulation resulted in significant baseline to post-placebo 
assessment changes in MDBF subscales between groups (F(6/162) = 2.4, p = 0.03, see Fig. 1), with significantly 
differences for mood (MDBF subscale ‘good/bad’ mood: F(2/82) = 3.27, p = 0.05) and calmness (MDBF subscale 
‘calm/agitated’ mood F(2/82) = 5.1, p = 0.0.01), but not for alertness (MDBF subscale ‘alert/tired’: F(2/82) = 0.007, 
p = 0.99). Post hoc tests indicated significant differences in change in calmness between the placebo conditions 
and the control condition (all p < 0.03) and in mood changes between the ‘placebo plus’ versus the ‘placebo 
only’ (p = 0.03) and ‘control’ conditions (p = 0.04), whereas the latter two groups did not differ from each other 
(p = 0.89). Effect sizes between the ‘control’, ‘placebo only’ and ‘placebo plus’ conditions for changes in calmness 
were d = 0.10, d = 0.68 and d = 0.91 as well as d = 0.03, d < 0.001 and d = 0.68 for mood changes.
In the green flux-experiment, perceived stress levels did not change significantly over time in the ‘control 
condition’, indicating that the placebo had no significant effect on the primary outcome when not provided 
with a rationale (F(2/23) = 2.2, p = 0.14). Groups significantly differed in their overall changes in PSS scores 
(F(4/150) = 5.2, p = 0.001, see Fig. 1), with significant short-term, i.e. baseline to post assessment, changes 
(F(2/75) = 11.2, p < 0.001) as well as significant mid-term, i.e. baseline to follow-up assessment, changes 
(F2/75) = 3.1, p = 0.05). Post hoc tests indicated significant differences in short- as well as mid-term changes 
between the ‘placebo plus’ and both the ‘control’ and the ‘placebo only’ group (all p < 0.05). Effect sizes of 
short-term changes in PSS scores were d = −0.22, d = −0.19 and d = 1.19 as well as d = −0.39, d = −0.29 and 
d = 0.27 for long-term changes in the ‘control’, ‘placebo only’ and ‘placebo plus’ conditions, respectively.
In the green morph-experiment, PSS scores did not change significantly over time in the ‘control condition’, 
indicating that the placebo had no significant effect on the primary outcome per se (F(2/61) = 0.29, p = 0.75). 
Groups differed significantly in changes in PSS scores from baseline (F(6/504) = 2.4, p = 0.03, see Fig. 1), with no 
significant differences in short-term changes (F(3/254( = 1.8, p = 0.14), but significant differences in mid-term 
changes, i.e. from baseline to follow-up assessment, (F(3/254) = 4.6, p = 0.004). For the latter, posthoc analyses 
indicated significant differences between the ‘placebo plus’ and all other conditions (all p < 0.05), while the lat-
ter did not differ from each other (all p > 0.10). Effect sizes of mid-term changes in PSS scores were d = −0.01, 
d = −0.01, d = −0.23 and d = 0.40 in the ‘control’, ‘control plus’, ‘placebo only’ and ‘placebo plus’ conditions, 
respectively.
Effects of condition on secondary outcome. To examine whether the experimental manipulation led 
to designated effects on perceived interpersonal behavior of the therapist, i.e. in terms of trustworthiness, friend-
liness and empathy, and response expectancy, mean values in the assessed two questions were examined between 
conditions in all experiments. In the green dot-experiment, results showed significantly higher perceived inter-
personal behavior of the therapist values in the ‘placebo plus’ conditions in comparison to the ‘placebo only’ 
conditions (F(1/54) = 6.4, p = 0.01, see Table 1), while conditions did not differ in response expectancy to the 
intervention (F(1/54) = 0.005, p = 0.94, see Table 1). In the green flux-experiment, participants in the ‘placebo 
only’ and the ‘placebo plus’ conditions differed significantly in perceived interpersonal behavior of the therapist 
values, with higher scores in the ‘placebo plus’ then the ‘placebo only’ condition (F(1/51) = 7.7, p = 0.01, see 
Table 1), while groups did not differ in response expectancy to the intervention (F(1/51) = 0.01, p = 0.93, see 
Table 1). In the green morph-experiment, participants differed significantly in perceived interpersonal behavior 
of the therapist (F(2/191) = 3.2, p = 0.04, see Table 1), with significantly higher values in both ‘plus’ conditions, 
i.e. with a trustworthy, friendly and empathetic experimenter, in comparison to the ‘placebo only’ condition 
(‘control plus’ versus ‘placebo only’: p = 0.04; ‘placebo plus’ versus ‘placebo only’: p = 0.03), while conditions 
with a trustworthy, friendly and empathetic experimenter did not differ in perceived empathy from each other 
(‘control plus’ versus ‘placebo plus’: p = 0.90). Conditions did not differ in response expectancy to the interven-
tion (F(2/191) = 1.0, p = 0.37; ‘control plus’ versus ‘placebo only’: p = 0.43; ‘placebo plus’ versus ‘placebo only’: 
p = 0.56; ‘control plus’ versus ‘placebo plus’: p = 0.43, see Table 1).
Discussion
We set out to assess the effects of otherwise inert placebo interventions provided with or without a psychological 
treatment rationale and with a neutral or trustworthy, friendly and empathetic behavior of the experimenter in 
three consecutive and independent experiments. In all three experiments, the employed placebos were inert 
when administered without a treatment rationale, but exerted significant effects on primary outcome when 
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Figure 1. Change scores in MDBF subscale and short- and medium-term change scores PSS score between 
groups in the green dot- (top), green flux- (middle) and green morph-experiment (bottom). To allow 
comparability with the results of the green dot-experiment, differences scores in the green flux- and green 
morph-experiments were inversed, thus positive differences scores indicate reductions in perceived stress. Bars 
represent mean values and error bars represent standard error of mean.
Experiment Condition
Perceived 
Empathy
Perceived 
Plausibility
Green dot
Placebo only 8.8 (0.2) 6.8 (0.4)
Placebo plus 9.5 (0.2) 6.8 (0.4)
Green flux
Placebo only 8.8 (0.2) 6.8 (0.3
Placebo plus 9.5 (0.2) 6.7 (0.4)
Green morph
Control plus 6.8 (0.5) 5.3 (0.5)
Placebo only 6.0 (0.5) 5.6 (0.5)
Placebo plus 6.9 (0.5) 5.5 (0.5)
Table 1. Perceived empathy and plausibility in all experiments (mean (standard error of mean)).
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provided with a psychological treatment rationale and a trustworthy, friendly and empathetic behavior of the 
experimenter. Although only tested in the green morph-experiment, the provision of trustworthy, friendly and 
empathetic relationship alone had no effects on primary outcome per se, indicating that in the respective exper-
iment, the observed placebo effects on primary outcome was not due to the interpersonal behavior of the exper-
imenter. These observed placebo effects differed in size, with large immediate and short-term effects and small 
to medium mid-term effects. Interestingly, considering that participants in the respective experiments received 
the same placebo, the provision of a psychological treatment rationale alone, i.e. without a trustworthy, friendly 
and empathetic interpersonal behavior of the experimenter, as well as the provision of a trustworthy, friendly and 
empathetic interpersonal behavior of the experimenter alone, i.e. without a psychological rationale, rendered the 
placebo effectless. Importantly, the experimental manipulation of both, i.e. providing a psychological treatment 
rationale as well as the interpersonal behavior of the experimenter, led on the one hand to the expected effects and 
differences in perceived empathy of the experimenter, while on the other hand perceived response expectancy 
appeared unaffected.
From an empirical perspective, it needs to be noted that the observed placebo effects are of the same magni-
tude to those seen in comparable populations with similar outcomes, but obtained with placebos administered 
within a biomedical context, i.e. with a biomedical treatment rationale. For example, Darragh et al.27 reported that 
the administration of placebo “antistress’ intranasal serotonin or oxytocin spray” in healthy volunteers resulted in 
significant reductions in perceived stress, with effect sizes similar to those reported in the green flux- and green 
morph-experiment, i.e. between d = 0.40 and d = 1.0. Also, Koban et al.14 reported a reduction in social pain of 
d = 1.04 after the administration of an otherwise inert nasal spray with biomedical treatment rationale, i.e. that 
the nasal spray is a “powerful analgesic that is also effective in reducing emotional pain and negative affect” in 
subjects who experienced a recent unwanted breakup of their romantic relationship. Furthermore, it needs to 
be noted that the observed placebo effects also show resemblance to those seen in assumingly non-placebo psy-
chological interventions. For example, psychological stress management trainings in healthy populations with 
comparable designs have been shown to yield reductions in perceives stress of the same magnitude than those 
obtained in the green flux- and the green morph-experiments28,29. Furthermore, although a direct comparison 
with effect sizes seen in psychotherapy trials is not warranted due to the fact that they are usually obtained in clin-
ical populations, it needs to be noted that the reported effect sizes would also be not unexpected for psychother-
apy trials30. Thus, our results show for the first time that placebos administered within a psychotherapeutic-like 
context and with a psychological treatment rationale have effects with approximately the same size as place-
bos provided within a biomedical context and with a biomedical treatment rationale as well as – assumingly 
non-placebo – psychological interventions.
From a theoretical perspective, the observation that the employed placebos only had effects when provided 
with a treatment rationale and in the context of a trustworthy, friendly and empathetic behavior of the experi-
menter both confirms and expands the current understanding of placebos and also sheds light on psychotherapy. 
First, studies examining the modulation of treatment effects by the patient-practitioner relationship have a long 
history. For example, Egbert et al.31 were able to demonstrate that “encouragement and education” led to a signif-
icant reduction in postoperative administration of narcotics, blindly rated objective and subjective report as well 
as shortened post-operative hospitalization. Likewise, a comparatively early study in primary care patients with 
minor illnesses showed that a positive consultation led to significantly better outcome in comparison to a negative 
consultation, irrespective of providing placebo or no treatment32. In their hallmark study, Kaptchuk et al.24 exam-
ined the effects of placebo acupuncture in irritable bowel syndrome, showing that this placebo procedure had 
moderate effects, which were almost doubled when provided with a friendly and empathetic patient-practitioner 
relationship. In psychotherapy, the relationship between patients/clients and therapists is an important determi-
nant of outcome30, showing its effect irrespective of its perceived importance by the researcher33. Also, the effects 
of an empathetic and supportive relationship have been found to be clinically relevant, equaling the effects of 
bona fide psychotherapies after controlling for researchers’ allegiance6. On the basis of the results of the green 
morph-experiment, we reason that neither a therapeutic treatment rationale nor the provision of trustworthy, 
friendly and empathetic relationship alone is sufficient to obtain an effect nor that they are additive, but that these 
two intervention components interact synergistically. It is important to keep in mind that in interventions the 
therapeutic relationship is not aimless, but always embedded in a therapeutic setting, i.e. provided with a thera-
peutic rationale. Considering the importance of the therapeutic alliance for psychotherapy, it is interesting to note 
that – in contrast to placebos provided with a biomedical treatment rationale24 – placebos with a psychological 
treatment rationale do not show any effect when provided in a neutral and technical way. Thus, it seems that the 
alliance becomes more important when the rationale is provided within a psychotherapeutic-like context. This 
finding resembles the results of a recent placebo study demonstrating that the effects of expectations – on the 
basis of a biomedical treatment rationale – are moderated by warmth and competence of the care provider34. 
However, while the results of the green morph-experiment support the importance of a trustworthy, friendly and 
empathetic relationship, we did not observe any effects of a trustworthy, friendly and empathetic relationship 
on response expectancies, indicating that these factors are independent from each other. It is possible that these 
differences between studies employing placebos with either a biomedical or psychological treatment rationale are 
due to differences in their familiarity, i.e. that taking the proverbial (placebo) pill is different from participating in 
a (placebo) psychological treatment in terms of having previous experiences and also possible with regard to the 
extent to which the respective intervention is socially grounded.
From a methodological point of view, the call to abandon randomized placebo-controlled trials in psychother-
apy research is well founded10, but that does not imply that the pursuit for specificity is futile. Rather, the examina-
tion of placebos provided with psychological treatment rationales would not only offer insights into the potential 
and the limits of expectancy and plausibility in the context of a therapeutic alliance, but also help to examine 
effects and mechanisms of these treatment components, regardless of their definition as being characteristic or 
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incidental to a given treatment theory35. Considering that the existence and size of specific effects of psychological 
interventions when compared to placebo conditions is functional to the operationalization of the latter5,36, still too 
little is known about the effects and mechanisms of placebos provided with a psychological treatment rationale.
Several aspects need critical examination. First, it can be argued that neither the intervention nor the way 
the relationship between experimenter and participant, resembles psychotherapy or the relationship between 
patients/clients and therapists in psychotherapy. However, with regard to the former, psychotherapy can take 
many forms, and as such, it is not defined by methods, but rather by its main goal to change feelings and behav-
iors. In this line of reasoning, our placebo interventions could well qualify as possible psychotherapeutic inter-
ventions. With regard to the latter, again, there is no universal definition of the relationship between patients/
clients and therapist in that psychotherapists and psychotherapies vary in the degree they rely on, position or 
use the relationship. Also, although our attempts to experimentally manipulate the relationship quality can be 
seen as pragmatic and superficial, it led to designated effects in the subjective perception of participants and also, 
it has been shown that “even (…) “superficial psychotherapy” (…) has very powerful effect(s) on patients (with 
postoperative pain)” (quote from31, quotation mark in original, parenthesis by authors). Second, our attempts to 
standardize the interpersonal behavior of the experimenters were guided by the caution not to over-regulate the 
interpersonal encounter. Thus, and for example, we did not standardize the frequency or intensity of eye contact 
or number of questions answered by the experimenters and it is possible that the interpersonal encounter differed 
in these aspects between participants and also between experimenters. Therefore, although we were able to vali-
date our approach by its effects on the secondary outcome, it is possible that this outcome was caused by different 
interpersonal behavior and processes. Third, we did not include a ‘control plus’ condition in the green dot- and 
the green flux-experiment and thus we can only speculate whether the observed effects of the ‘placebo plus’ con-
ditions are due to the interaction of response expectancy and trustworthy, friendly and empathetic interaction 
of experimenter with participants or solely driven by the later. Fourth, our primary outcome was restricted to 
subjective parameters, i.e. momentary mood and perceived stress by self-report. Although this kind of assess-
ment and outcome is customary in the evaluation of psychological interventions, the inclusion of physiological 
parameters would have corroborated our effects on subjective outcome. Fifth, we did not assess the secondary 
outcome in control conditions as the used items explicitly referred to an interventional context, e.g. I feel that the 
therapist is trustworthy. As both the use of this wording would have changed the provided rational for the control 
conditions as much as a rephrased wording would have rendered these items incomparable between conditions, 
we did not assess secondary outcome in the control conditions. However, the verbal and interpersonal behavior 
of experimenters in the control conditions were manualized as in all other conditions (see Appendix). Finally, 
we tested only healthy participants to increase internal validity. Although this might preclude direct implica-
tions for clinical research, we are confident that our results are informative for both placebo and psychotherapy 
research and that in future, this should be expanded also to clinical populations. Also, it needs to be noted that 
we employed three different variations of the same theme, i.e. ‘green’ and ‘moving’. The majority of participants 
were psychology students at the Universities of Basel and although participants were asked not disclose study 
details to fellow students, we changed the appearance of the placebos between experiments to minimize possible 
unblinding effects.
In conclusion, our results show that placebos with a psychological treatment rationale are possible and effec-
tive, when provided in a trustworthy, friendly and empathetic relationship, at least in healthy subjects. This 
opens the door for genuine placebo research in the realm of psychotherapy and the results of this research would 
not only be of interest for placebo research, but also inform the conceptualization and testing of psychological 
interventions.
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